NivobotulinumtoxinA in the Treatment of Glabellar Lines With or Without Concurrent Treatment of Lateral Canthal Lines in Two Phase 3 Clinical Trials.

MLA

Coleman, William, et al. “NivobotulinumtoxinA in the Treatment of Glabellar Lines With or Without Concurrent Treatment of Lateral Canthal Lines in Two Phase 3 Clinical Trials.” Aesthetic Surgery Journal, Nov. 2024. EBSCOhost, https://doi.org/10.1093/asj/sjae233.

APA

Coleman, W., Bertucci, V., Humphrey, S., Kaufman-Janette, J., Keaney, T., Pariser, D., Solish, N., Wirta, D., & Weiss, R. A. (2024). NivobotulinumtoxinA in the Treatment of Glabellar Lines With or Without Concurrent Treatment of Lateral Canthal Lines in Two Phase 3 Clinical Trials. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjae233

Chicago

Coleman, William, Vince Bertucci, Shannon Humphrey, Joely Kaufman-Janette, Terrence Keaney, David Pariser, Nowell Solish, David Wirta, and Robert A Weiss. 2024. “NivobotulinumtoxinA in the Treatment of Glabellar Lines With or Without Concurrent Treatment of Lateral Canthal Lines in Two Phase 3 Clinical Trials.” Aesthetic Surgery Journal, November. doi:10.1093/asj/sjae233.